Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Di Carlo

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Cancer Research|August 24, 2016
Interleukin-30 Promotes Breast Cancer Growth and ProgressionIrma Airoldi, Claudia Cocco, Carlo Sorrentino, et al.
Journal of Hematology & Oncology|October 12, 2022
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortalityCarlo Sorrentino, Luigi D'Antonio, Stefania Livia Ciummo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependentPatrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, et al.
Blood|May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic targetIrma Airoldi, Claudia Cocco, Nicola Giuliani, et al.
Frontiers in Immunology|January 23, 2026
Pazopanib-associated remodeling of platelet-immune cell crosstalk and immune suppressive platelet-derived extracellular vesicles in metastatic RCCGianpiero Lupoli, Stefano Bergamini, Jeannette Salsetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunityMichela Spadaro, Elena Ambrosino, Manuela Iezzi, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
International Journal of Cancer|April 22, 2003
Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.
Journal of Leukocyte Biology|July 28, 2007
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in micePasquale Buanne, Emma Di Carlo, Lorenzo Caputi, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Cancer Research|August 24, 2016
Interleukin-30 Promotes Breast Cancer Growth and ProgressionIrma Airoldi, Claudia Cocco, Carlo Sorrentino, et al.
Journal of Hematology & Oncology|October 12, 2022
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortalityCarlo Sorrentino, Luigi D'Antonio, Stefania Livia Ciummo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependentPatrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, et al.
Blood|May 14, 2008
Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic targetIrma Airoldi, Claudia Cocco, Nicola Giuliani, et al.
Frontiers in Immunology|January 23, 2026
Pazopanib-associated remodeling of platelet-immune cell crosstalk and immune suppressive platelet-derived extracellular vesicles in metastatic RCCGianpiero Lupoli, Stefano Bergamini, Jeannette Salsetta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunityMichela Spadaro, Elena Ambrosino, Manuela Iezzi, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
International Journal of Cancer|April 22, 2003
Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni, et al.
Journal of Leukocyte Biology|July 28, 2007
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in micePasquale Buanne, Emma Di Carlo, Lorenzo Caputi, et al.
Pageof 10